News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
SCHLEIFER LEONARD S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2023 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Gifted 53,807 shares
@ $0 |
|
| 04/07/2022 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 4,461 shares
@ $710.05, valued at
$3.2M
Sold 2,653 shares
@ $710.04, valued at
$1.9M
|
|
| 04/04/2022 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 2,886 shares
@ $710.01, valued at
$2M
|
|
| 11/19/2021 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 173,491 shares
@ $651.96, valued at
$113.1M
Paid exercise price by delivering 185,646 shares
@ $651.96, valued at
$121M
Exercised 281,250 options to buy
@ $179.13, valued at
$50.4M
Exercised 239,063 options to buy
@ $270.43, valued at
$64.6M
|
|
| 08/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2019 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 64,754 shares
@ $377.16, valued at
$24.4M
Paid exercise price by delivering 97,209 shares
@ $377.16, valued at
$36.7M
Exercised 124,900 options to buy
@ $21.25, valued at
$2.7M
Exercised 187,500 options to buy
@ $21.25, valued at
$4M
Granted 81,278 options to buy
@ $372.46, valued at
$30.3M
Granted 25,155 rights
@ $0 |
|
| 03/22/2019 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Exercised 100 options to buy
@ $21.25, valued at
$2.1k
|
|
| 12/14/2018 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 96,079 shares
@ $377.31, valued at
$36.3M
Paid exercise price by delivering 64,052 shares
@ $377.31, valued at
$24.2M
Exercised 187,500 options to buy
@ $16.8, valued at
$3.2M
Exercised 125,000 options to buy
@ $16.8, valued at
$2.1M
Granted 129,013 options to buy
@ $381.4, valued at
$49.2M
|
|
| 12/13/2017 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 14,230 shares
@ $385.08, valued at
$5.5M
Paid exercise price by delivering 121,586 shares
@ $385.08, valued at
$46.8M
Exercised 250,000 options to buy
@ $21.92, valued at
$5.5M
Granted 139,474 options to buy
@ $378.98, valued at
$52.9M
|
|
| 12/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/18/2015 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Granted 172,723 options to buy
@ $555.67, valued at
$96M
|
|
| 09/03/2015 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 5,745 shares
@ $506.37, valued at
$2.9M
Paid exercise price by delivering 762 shares
@ $506.37, valued at
$385.9k
Exercised 7,226 options to buy
@ $402.69, valued at
$2.9M
|
|
| 01/05/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/18/2014 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Granted 240,000 options to buy
@ $52.03, valued at
$12.5M
Granted 203,204 options to buy
@ $399.66, valued at
$81.2M
|
|
| 11/12/2014 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Sold 3,493 shares
@ $400, valued at
$1.4M
Sold 37,464 shares
@ $400.22, valued at
$15M
Sold 4,860 shares
@ $401.12, valued at
$1.9M
|
|
| 11/04/2014 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Sold 3,453 shares
@ $400.11, valued at
$1.4M
|
|
| 10/29/2014 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 5,145 shares
@ $402.69, valued at
$2.1M
Paid exercise price by delivering 857 shares
@ $402.69, valued at
$345.1k
Paid exercise price by delivering 7,226 shares
@ $402.69, valued at
$2.9M
Paid exercise price by delivering 125,198 shares
@ $402.69, valued at
$50.4M
Sold 12,322 shares
@ $400.52, valued at
$4.9M
Sold 10,381 shares
@ $401.45, valued at
$4.2M
Sold 3,318 shares
@ $402.54, valued at
$1.3M
Sold 12,250 shares
@ $403.38, valued at
$4.9M
Sold 2,250 shares
@ $404.46, valued at
$910k
Sold 5,900 shares
@ $405.76, valued at
$2.4M
Sold 14,052 shares
@ $406.5, valued at
$5.7M
|
|
| 12/17/2013 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Granted 187,500 options to buy
@ $30.63, valued at
$5.7M
Granted 239,063 options to buy
@ $270.43, valued at
$64.6M
|
|
| 10/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2013 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Sold 20,400 shares
@ $225.01, valued at
$4.6M
Sold 850 shares
@ $226.26, valued at
$192.3k
Sold 500 shares
@ $227.4, valued at
$113.7k
Sold 622 shares
@ $228.04, valued at
$141.8k
Sold 5,300 shares
@ $231.18, valued at
$1.2M
Sold 700 shares
@ $232.18, valued at
$162.5k
Sold 5,000 shares
@ $233.34, valued at
$1.2M
Sold 400 shares
@ $235.75, valued at
$94.3k
Sold 3,327 shares
@ $236.47, valued at
$786.7k
Sold 2,300 shares
@ $237.31, valued at
$545.8k
Sold 3,089 shares
@ $238.65, valued at
$737.2k
|
|
| 03/21/2013 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Sold 3,655 shares
@ $175.02, valued at
$639.7k
|
|
| 03/07/2013 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Gifted 59,271 shares
@ $0
Sold 19,146 shares
@ $175.21, valued at
$3.4M
Sold 60,803 shares
@ $175.28, valued at
$10.7M
Sold 8,200 shares
@ $176.1, valued at
$1.4M
Sold 3,534 shares
@ $175.13, valued at
$618.9k
|
|
| 12/17/2012 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Granted 187,500 options to buy
@ $21.25, valued at
$4M
Granted 281,250 options to buy
@ $179.13, valued at
$50.4M
|
|
| 05/02/2012 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Sold 2,300 shares
@ $133.86, valued at
$307.9k
Sold 58,494 shares
@ $134.55, valued at
$7.9M
Sold 39,106 shares
@ $135.29, valued at
$5.3M
Sold 100 shares
@ $136.57, valued at
$13.7k
|
|
| 02/15/2012 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 27,475 shares
@ $111.01, valued at
$3M
Paid exercise price by delivering 95,429 shares
@ $111.01, valued at
$10.6M
Paid exercise price by delivering 43,757 shares
@ $111.01, valued at
$4.9M
Paid exercise price by delivering 95,016 shares
@ $111.01, valued at
$10.5M
Paid exercise price by delivering 1,801 shares
@ $111.01, valued at
$199.9k
Paid exercise price by delivering 6,257 shares
@ $111.01, valued at
$694.6k
Exercised 234,616 options to buy
@ $13, valued at
$3.1M
Exercised 15,384 options to buy
@ $13, valued at
$200k
Exercised 250,000 options to buy
@ $19.43, valued at
$4.9M
Granted 43,757 options to buy
@ $111.01, valued at
$4.9M
Granted 1,801 options to buy
@ $111.01, valued at
$199.9k
|
|
| 12/20/2011 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 134,585 shares
@ $52.03, valued at
$7M
Paid exercise price by delivering 53,344 shares
@ $52.03, valued at
$2.8M
Granted 187,500 options to buy
@ $16.8, valued at
$3.2M
Exercised 250,000 options to buy
@ $28.01, valued at
$7M
Granted 160,000 options to buy
@ $52.03, valued at
$8.3M
|
|
| 09/08/2011 |
4
| SCHLEIFER LEONARD S (CEO & President) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Sold 90 shares
@ $63.01, valued at
$5.7k
Sold 180 shares
@ $65.56, valued at
$11.8k
Sold 630 shares
@ $66.54, valued at
$41.9k
Converted 7,000 shares
@ $0
Sold 3,500 shares
@ $65.27, valued at
$228.4k
Sold 2,700 shares
@ $66.42, valued at
$179.3k
Sold 300 shares
@ $67.5, valued at
$20.3k
Sold 500 shares
@ $68.42, valued at
$34.2k
Converted 7,000 options to buy
@ $0 |
|
| 12/20/2010 |
4
| SCHLEIFER LEONARD S (CEO and President) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Granted 125,000 options to buy
@ $30.63, valued at
$3.8M
|
|
| 12/22/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2009 |
4
| SCHLEIFER LEONARD S (CEO and President) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 66,138 shares
@ $19.89, valued at
$1.3M
Paid exercise price by delivering 37,155 shares
@ $19.89, valued at
$739k
Exercised 150,000 options to buy
@ $8.77, valued at
$1.3M
|
|
|
|